These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10705965)

  • 1. Tryparedoxin and tryparedoxin peroxidase.
    Montemartini M; Nogoceke E; Gommel DU; Singh M; Kalisz HM; Steinert P; Flohé L
    Biofactors; 2000; 11(1-2):71-2. PubMed ID: 10705965
    [No Abstract]   [Full Text] [Related]  

  • 2. Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata.
    Tetaud E; Fairlamb AH
    Mol Biochem Parasitol; 1998 Oct; 96(1-2):111-23. PubMed ID: 9851611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryparedoxin and tryparedoxin peroxidase.
    Flohé L; Steinert P; Hecht HJ; Hofmann B
    Methods Enzymol; 2002; 347():244-58. PubMed ID: 11898414
    [No Abstract]   [Full Text] [Related]  

  • 4. Tryparedoxin II from Crithidia fasciculata.
    Montemartini M; Steinert P; Singh M; Flohé L; Kalisz HM
    Biofactors; 2000; 11(1-2):65-6. PubMed ID: 10705963
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytoplasmic localization of the trypanothione peroxidase system in Crithidia fasciculata.
    Steinert P; Dittmar K; Kalisz HM; Montemartini M; Nogoceke E; Rohde M; Singh M; Flohé L
    Free Radic Biol Med; 1999 Apr; 26(7-8):844-9. PubMed ID: 10232827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1H, 15N and 13C resonance assignments and secondary structure of tryparedoxin-I from Crithidia fasciculata.
    Krumme D; Hecht HJ; Menge U; Ross A; Wray V; Flohé L
    J Biomol NMR; 2002 Apr; 22(4):375-6. PubMed ID: 12018487
    [No Abstract]   [Full Text] [Related]  

  • 7. Catalytic characteristics of tryparedoxin.
    Gommel DU; Nogoceke E; Morr M; Kiess M; Kalisz HM; Flohé L
    Eur J Biochem; 1997 Sep; 248(3):913-8. PubMed ID: 9342246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallisation of tryparedoxin I from Crithidia fasciculata.
    Kalisz HM; Hofmann B; Nogoceke E; Gommel DU; Flohé L; Hecht HJ
    Biofactors; 2000; 11(1-2):73-5. PubMed ID: 10705966
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystallization of recombinant Crithidia fasciculata tryparedoxin.
    Alphey MS; Tetaud E; Gourley DG; Fairlamb AH; Hunter WN
    J Struct Biol; 1999 Jun; 126(1):76-9. PubMed ID: 10329491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of tryparedoxin I from Crithidia fasciculata.
    Guerrero SA; Montemartini M; Spallek R; Hecht HJ; Steinert P; Flohé L; Singh M
    Biofactors; 2000; 11(1-2):67-9. PubMed ID: 10705964
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequence analysis of the tryparedoxin peroxidase gene from Crithidia fasciculata and its functional expression in Escherichia coli.
    Montemartini M; Nogoceke E; Singh M; Steinert P; Flohé L; Kalisz HM
    J Biol Chem; 1998 Feb; 273(9):4864-71. PubMed ID: 9478927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of active-site cysteine residues in the peroxiredoxin-type tryparedoxin peroxidase of Crithidia fasciculata.
    Montemartini M; Kalisz HM; Hecht HJ; Steinert P; Flohé L
    Eur J Biochem; 1999 Sep; 264(2):516-24. PubMed ID: 10491099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structures of the tryparedoxin-tryparedoxin peroxidase couple unveil the structural determinants of Leishmania detoxification pathway.
    Fiorillo A; Colotti G; Boffi A; Baiocco P; Ilari A
    PLoS Negl Trop Dis; 2012; 6(8):e1781. PubMed ID: 22928053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic properties, localization, and in vivo role of Px IV, a novel tryparedoxin peroxidase of Trypanosoma brucei.
    Liu I; Bogacz M; Schaffroth C; Dirdjaja N; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016 Jun; 207(2):84-8. PubMed ID: 27262262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence, heterologous expression and functional characterization of a novel tryparedoxin from Crithidia fasciculata.
    Montemartini M; Kalisz HM; Kiess M; Nogoceke E; Singh M; Steinert P; Flohé L
    Biol Chem; 1998; 379(8-9):1137-42. PubMed ID: 9792447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence, heterologous expression and functional characterization of tryparedoxin1 from Crithidia fasciculata.
    Guerrero SA; Flohé L; Kalisz HM; Montemartini M; Nogoceke E; Hecht HJ; Steinert P; Singh M
    Eur J Biochem; 1999 Feb; 259(3):789-94. PubMed ID: 10092865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization and preliminary X-ray analysis of tryparedoxin I from Crithidia fasciculata.
    Kalisz HM; Nogoceke E; Gommel DU; Hofmann B; Flohé L; Hecht HJ
    Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):696-8. PubMed ID: 10089473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high resolution crystal structure of recombinant Crithidia fasciculata tryparedoxin-I.
    Alphey MS; Leonard GA; Gourley DG; Tetaud E; Fairlamb AH; Hunter WN
    J Biol Chem; 1999 Sep; 274(36):25613-22. PubMed ID: 10464297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins.
    Alphey MS; Bond CS; Tetaud E; Fairlamb AH; Hunter WN
    J Mol Biol; 2000 Jul; 300(4):903-16. PubMed ID: 10891277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic control analysis of the Trypanosoma cruzi peroxide detoxification pathway identifies tryparedoxin as a suitable drug target.
    González-Chávez Z; Olin-Sandoval V; Rodíguez-Zavala JS; Moreno-Sánchez R; Saavedra E
    Biochim Biophys Acta; 2015 Feb; 1850(2):263-73. PubMed ID: 25450181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.